SNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
Sponsor: Eir Biotherapies S.r.l.
Phase:
Disease: Locally advanced pancreatic ductal adenocarcinoma
EU trial number: 2026-525714-59-00
Population: Adults with locally advanced pancreatic ductal adenocarcinoma who received RR001 in the parent SNIPER study, completed its end-of-study visit, and consent to long-term follow-up.
Register Investigator Interest
Interested in offering this trial to suitable patients?